Notice Pursuant to the National Cooperative Research and Production Act of 1993-Joint Venture To Perform Project Entitled Robotic Rehabilitation of Aging Water Pipelines, 14190-14191 [2010-6274]

Download as PDF 14190 Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices Drug Schedule Dihydromorphine (9145) ............... Amphetamine (1100) .................... Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Methadone intermediate (9254) ... Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Oripavine (9330) ........................... Oxymorphone (9652) ................... I II II II II II II II II II II II II II Alpha-ethyltryptamine (7249) ....... Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... Drug II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than May 24, 2010. Dated: March 16, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Drug BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration srobinson on DSKHWCL6B1PROD with NOTICES Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 4, 2009, Sigma Aldrich Research Biochemicals, Inc., 1–3 Strathmore Road, Natick, Massachusetts 01760–2447, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances in schedules I and II: Schedule Cathinone (1235) .......................... Methcathinone (1237) .................. Aminorex (1585) ........................... VerDate Nov<24>2008 16:24 Mar 23, 2010 I I I Jkt 220001 Springfield, VA 22152; and must be filed no later than May 24, 2010. I I I Dated: March 16, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Schedule 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (MDMA) (7405). Psilocybin (7437) .......................... 5-Methoxy-N,Ndiisopropyltryptamine (7439). 1-[1-(2Thienyl)cyclohexyl]piperidine (TCP) (7470). N-Benzylpiperazine (BZP) (7493) Heroin (9200) ............................... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Nabilone (7379) ............................ 1-Phenylcyclohexylamine (7460) Phencyclidine (7471) .................... Cocaine (9041 .............................. Codeine (9050) ............................. Diprenorphine (9058) ................... Ecgonine (9180) ........................... [FR Doc. 2010–6420 Filed 3–23–10; 8:45 am] Drug Schedule Drug I DEPARTMENT OF JUSTICE I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II The company plans to manufacture reference standards. Any other such applicant, and any person who is presently registered with DEA to manufacture such a substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 BILLING CODE 4410–09–P I Schedule Levomethorphan (9210) ............... Levorphanol (9220) ...................... Meperidine (9230) ........................ Metazocine (9240) ........................ Methadone (9250) ........................ Morphine (9300). II Thebaine (9333) ........................ Levo-alphacetylmethadol (9648) .. Remifentanil (9739) ...................... Carfentanil (9743) ......................... Fentanyl (9801) ............................ [FR Doc. 2010–6415 Filed 3–23–10; 8:45 am] Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 8, 2009, Archimica, Inc., 2460 W. Bennett Street, Springfield, Missouri 65807–1229, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of controlled substance listed in schedule I. The company plans to manufacture the listed controlled substance in bulk for sale to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 24, 2010. Dated: March 16, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–6442 Filed 3–23–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Joint Venture To Perform Project Entitled Robotic Rehabilitation of Aging Water Pipelines Notice is hereby given that, on February 3, 2010, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et sect. (‘‘the Act’’), Joint E:\FR\FM\24MRN1.SGM 24MRN1 Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices Venture to Perform Project Entitled Robotic Rehabilitation of Aging Water Pipelines (‘‘Robotic Rehabilitation of Aging Water Pipelines’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Fibrwrap Construction, Inc., Ontario, CA; Fyfe Company, LLC, San Diego, CA; and the University of California-Irvine, Irvine, CA. The general area of Robotic Rehabilitation of Aging Water Pipelines’s planned activity is to develop a prototype robot to apply high-performance, low-cost carbon fiber reinforcement inside water transmission pipes, allowing trenchless repair and rehabilitation of aging pipelines. Patricia A. Brink, Deputy Director of Operations Antitrust Division. [FR Doc. 2010–6274 Filed 3–23–10; 8:45 am] BILLING CODE M DEPARTMENT OF JUSTICE Antitrust Division srobinson on DSKHWCL6B1PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group On: Diesel After Treatment Accelerated Aging Cycles—Heavy Duty Notice is hereby given that, on February 23, 2010, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute— Cooperative Research Group on Diesel After Treatment Accelerated Aging Cycles—Heavy-Duty (‘‘DAAAC–HD’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Caterpillar Inc., Peoria, IL has been added as a party to this venture. VerDate Nov<24>2008 16:24 Mar 23, 2010 Jkt 220001 No other changes have been made in either the membership or planned activity of the group research project. Membership in this group remains open, and DAAAC–HD intends to file additional written notifications disclosing all changes in membership. On February 2, 2009, DAAAC–HD filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 2, 2009 (74 FR 8813). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 2010–6270 Filed 3–23–10; 8:45 am] BILLING CODE M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to The National Cooperative Research and Production Act of 1993—American Society of Mechanical Engineers Notice is hereby given that, on February 25, 2010, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq.. (‘‘the Act’’), the American Society of Mechanical Engineers (‘‘ASME’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, since November 11, 2009, ASME has published six new standards, initiated three new standards activities, and withdrawn two standards within the general nature and scope of ASME’s standards development activities, as specified in its original notification. More detail regarding these changes can be found at www.asme.org. On September 15, 2004, ASME filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on October 13, 2004 (69 FR 60895). The last notification was filed with the Department on November 13, 2009. A notice was published in the Federal PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 14191 Register pursuant to Section 6(b) of the Act on December 9, 2009 (74 FR 65156). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 2010–6269 Filed 3–23–10; 8:45 am] BILLING CODE M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—IMS Global Learning Consortium, Inc. Notice is hereby given that, on February 16, 2010, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), IMS Global Learning Consortium Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Sigong Media, Seoul, REPUBLIC OF KOREA; SungKyunKwan University, Suwan, Gyeonggi—do, REPUBLIC OF KOREA; State University of New York at Delhi, Delhi, NY; Texas A&M—Commerce, Commerce, TX; and Touro University Worldwide, Westlake Village, CA have been added as parties to this venture. Also, LearnGauge, LLC, Okemos, MI; Inigral, Inc., San Francisco, CA; Norwegian Secretariat for Standardization Learning Technology (NSSL), Blindern, Oslo, NORWAY; and Levelland Independent School District, Levelland, TX have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and IMS Global Learning Consortium Inc. intends to file additional written notifications disclosing all changes in membership. On April 7, 2000, IMS Global Learning Consortium Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on September 13, 2000 (65 FR 55283). The last notification was filed with the Department on December 1, 2009. A notice was published in the Federal E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 75, Number 56 (Wednesday, March 24, 2010)]
[Notices]
[Pages 14190-14191]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6274]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Joint Venture To Perform Project Entitled 
Robotic Rehabilitation of Aging Water Pipelines

    Notice is hereby given that, on February 3, 2010, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et sect. (``the Act''), Joint

[[Page 14191]]

Venture to Perform Project Entitled Robotic Rehabilitation of Aging 
Water Pipelines (``Robotic Rehabilitation of Aging Water Pipelines'') 
has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing (1) the identities 
of the parties to the venture and (2) the nature and objectives of the 
venture. The notifications were filed for the purpose of invoking the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: Fibrwrap Construction, Inc., Ontario, CA; Fyfe 
Company, LLC, San Diego, CA; and the University of California-Irvine, 
Irvine, CA. The general area of Robotic Rehabilitation of Aging Water 
Pipelines's planned activity is to develop a prototype robot to apply 
high-performance, low-cost carbon fiber reinforcement inside water 
transmission pipes, allowing trenchless repair and rehabilitation of 
aging pipelines.

Patricia A. Brink,
Deputy Director of Operations Antitrust Division.
[FR Doc. 2010-6274 Filed 3-23-10; 8:45 am]
BILLING CODE M